AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2020
May 18, 2020
32106_dirs_2020-05-18_d3a8d10f-7f11-415d-8853-1d133034e6e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-05-14
Reporting Person: Casdin Partners Master Fund, L.P. (10% Owner)
Reporting Person: Casdin Capital, LLC (10% Owner)
Reporting Person: Casdin Partners GP, LLC (10% Owner)
Reporting Person: Casdin Eli (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-14 | Common Stock, par value $.001 per share | P | 1904762 | $10.50 | Acquired | 4373333 | Direct |
Footnotes
F1: On May 14, 2020, Casdin Partners Master Fund, LP entered into a Share Purchase Agreement with the Issuer for the purchase of the securities reported herein, with a closing date of May 26, 2020 and subject to certain conditions as set forth in the Share Purchase Agreement.
F2: The securities are owned directly by Casdin Partners Master Fund, LP and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, LP, (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.